Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ultra-early STatin in Patients With Aneurysmal subaRachnoid Hemorrhage (Ue-STAR): a Randomized Controlled Trial

NCT06559072 is registered in ClinicalTrials.gov with The George Institute as lead sponsor.

NCT NCT06559072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06559072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ultra-early STatin in Patients With Aneurysmal subaRachnoid Hemorrhage (Ue-STAR): a Randomized Controlled Trial
Lead sponsor
The George Institute
Phase
Phase 3
Overall status
Withdrawn
Start date
September 1, 2024
Completion date
September 1, 2026
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aneurysmal subarachnoid hemorrhage, hemorrhage, aneurysmal subarachnoid, subarachnoid hemorrhage, subarachnoid hemorrhage, aneurysmal